Epoetin Alfa FDA Link

A recombinant glycosylated form of erythropoietin which stimulates the differentiation and proliferation of erythroid precursors. It is used for the treatment of ANEMIA associated with CHRONIC RENAL FAILURE in dialysis and predialysis patients.

Also Known As:

Epogen; Binocrit; Epoetin Alfa Hexal; Eprex; HX575; HX575 Compound; Heberitro; Procrit; Recombinant 1-165 Erythropoietin, Glycoform Alpha; Alfa Hexal, Epoetin; Alfa, Epoetin; Compound, HX575; Hexal, Epoetin Alfa; Recombinant 1 165 Erythropoietin, Glycoform Alpha; 1-165-Erythropoietin (human clone lambdaHEPOFL13 protein moiety), glycoform alpha

Carbohydrates: 22516
- Glycoconjugates: 1370
  - Glycoproteins: 25180
    - Colony-Stimulating Factors: 1607
      - Erythropoietin: 12372
        Epoetin Alfa: 681
Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Intercellular Signaling Peptides and Proteins: 30151
    - Cytokines: 168239
      - Hematopoietic Cell Growth Factors: 13
        Colony-Stimulating Factors: 1607
        Erythropoietin: 12372
        Epoetin Alfa: 681
  - Glycoproteins: 25180
    - Colony-Stimulating Factors: 1607
      - Erythropoietin: 12372
        Epoetin Alfa: 681
- Peptides: 84029
  - Intercellular Signaling Peptides and Proteins: 30151
    - Cytokines: 168239
      - Hematopoietic Cell Growth Factors: 13
        Colony-Stimulating Factors: 1607
        Erythropoietin: 12372
        Epoetin Alfa: 681
Biological Factors: 2560
- Intercellular Signaling Peptides and Proteins: 30151
  - Cytokines: 168239
    - Hematopoietic Cell Growth Factors: 13
      - Colony-Stimulating Factors: 1607
        Erythropoietin: 12372
        Epoetin Alfa: 681

R Kaczmarski Selected Research

R Kaczmarski Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure